STOCK TITAN

[Form 4] Cadre Holdings, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Brad Williams, President of Cadre Holdings, Inc. (ticker: CDRE), reported a sale of 4,132 shares of the company's common stock on 09/23/2025 at a price of $37 per share. Following the reported transaction, the reporting person beneficially owned 114,353 shares. The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025, and the filing was signed on September 25, 2025.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider sale under a pre-established 10b5-1 plan; modest size relative to typical insider holdings.

The reported disposal of 4,132 shares at $37 each was executed under a 10b5-1 plan, indicating the transaction was pre-arranged rather than opportunistic. The remaining beneficial ownership of 114,353 shares provides context for the insider's stake but the filing does not state total outstanding shares, so percent ownership cannot be calculated from this form alone. No derivative transactions or additional purchases were reported.

TL;DR: Disclosure aligns with Section 16 reporting rules and cites a 10b5-1 plan, reflecting standard compliance practice.

The Form 4 properly identifies the reporting person as an officer (President) and discloses the transaction date, amount, price, and post-transaction holdings. The explicit mention of a Rule 10b5-1 plan reduces concerns about timing-based insider trading, but the filing itself provides no commentary on the plan's parameters beyond the adoption date.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Williams Brad

(Last) (First) (Middle)
C/O CADRE HOLDINGS, INC.
13386 INTERNATIONAL PKWY

(Street)
JACKSONVILLE FL 32218

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT
3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share ("Common Stock") 09/23/2025 S(1) 4,132 D $37 114,353 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.
/s/ Brad Williams 09/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Cadre Hldgs Inc

NYSE:CDRE

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.72B
29.04M
29.12%
69.63%
4.85%
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE